AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring
Go back to AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring| Amgen Inc (NASDAQ: AMGN) | Delayed: 366.05 -0.19 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $366.24 | 52 Week High | $176.85 | |||
| Open | $369.23 | 52 Week Low | $133.64 | |||
| Day High | $371.00 | P/E | 55.13 | |||
| Day Low | $364.86 | EPS | $6.64 | |||
| Volume | 1,548,438 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 1,683,822 | |||||
